ClearPoint Neuro, Inc. (CLPT) Tops Q3 EPS by 4c; Offers FY22 Revenue Guidance

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q3 EPS of ($0.15), $0.04 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $5.41 million.

GUIDANCE:

ClearPoint Neuro, Inc. sees FY2022 revenue of $21-22 million, versus the consensus of $21.3 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• After-Hours Stock Movers: FDX, CBRS, NKE